Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease
Acta Ophthalmologica · 2026
DOI: 10.1111/aos.17556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Mikael Thomassen Neset und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Tears, Biomarkers, Graves Ophthalmopathy, Meibomian Glands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Regional Health Authorities of Western Norway, Novo Nordisk Foundation Center for Basic Metabolic Research.
Abstract (Originalsprache)
Purpose
To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED).
Methods
We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface status and Meibomian gland function. Tear fluid was analysed for 40 inflammatory biomarkers by a Luminex multiplex bead assay. The parameters were compared across subgroups.
Results
GD patients with TED had significantly higher median (min–max) Ocular Surface Disease Index (OSDI) score than GD patients without TED, with a median score of 31.4 (0–86.4) compared to 7.3 (0–45.8) ( p < 0.01). Eleven of 50 patients with moderate‐to‐severe and sight‐threatening TED had a meibum quality score above seven, compared to none of the 20 patients with mild TED ( p = 0.027). Tear fluid levels of chemokine (C–C motif) ligand 2 (CCL2) were significantly ( p = 0.003) higher in GD patients compared to healthy subjects. CD40 ligand (CD40L) and CCL2 were higher in GD patients with TED compared with GD patients without TED ( p = 0.002 and 0.013, respectively). As a combined biomarker to distinguish between GD patients with and without TED, OSDI score together with tear fluid levels of CCL2 and CD40L produced an area under the receiver operating characteristic (ROC) curve of 0.80, with sensitivity of 0.69 at a fixed specificity of 0.80.
Conclusions
Our findings demonstrate increased tear fluid levels of CD40L and CCL2 in patients with TED, indicating their potential as diagnostic biomarkers. Increased ocular discomfort in patients with TED could be related to impaired meibum quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
- Department of Medicine, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
ORCID-Profile: Hans Olav Ueland
Förderung
- The Regional Health Authorities of Western Norway
- Novo Nordisk Foundation Center for Basic Metabolic Research
Zitieren
APA
Neset, M. T., Nilsen, R. M., Løvås, K., Halsøy, K., Reikvam, H., Stokland, A. M., Ueland, G. Å., Wolff, A. S. B., Aass, H. C. D., Reppe, S., Husebye, E. S., Rødahl, E., Utheim, T. P., & Ueland, H. O. (2026). Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. Acta Ophthalmologica. https://doi.org/10.1111/aos.17556
Vancouver
Neset MT, Nilsen RM, Løvås K, Halsøy K, Reikvam H, Stokland AM, et al. Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. Acta Ophthalmologica. 2026. doi:10.1111/aos.17556
BibTeX
@article{Neset2026,
author = {Neset, Mikael Thomassen and Nilsen, Roy Miodini and Løvås, Kristian and Halsøy, Kathrine and Reikvam, Håkon and Stokland, Ann-Elin Meling and Ueland, Grethe Åstrøm and Wolff, Anette S B and Aass, Hans Christian D and Reppe, Sjur and Husebye, Eystein Sverre and Rødahl, Eyvind and Utheim, Tor Paaske and Ueland, Hans Olav},
title = {Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease},
journal = {Acta Ophthalmologica},
year = {2026},
doi = {10.1111/aos.17556}
}
EUVIMED